By; Kolbot

Patent Applications and Registrations

Patent applications and USPTO patent grants for By; Kolbot.The latest application filed is for "crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1h-pyrazolo[3,4-d]pyrimidin-1- -yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-- 2-enenitrile".

Company Profile

2.7.12

By; Kolbot - San Ramon CA
By; Kolbot - Hayward CA
By; Kolbot - Monterey Park CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crystalline Forms Of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1h-pyrazolo[3,4-d]pyrimidin-1- -yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-- 2-enenitrile App 20210221818 - Phiasivongsa; Pasit ; et al.	2021-07-22
Crystalline Forms Of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1h-pyrazolo[3,4-d]pyrimidin-1- -yl]piperidine-1-carbonyl]-4,4-dimethylpent-2-enenitrile App 20210206772 - Phiasivongsa; Pasit ; et al.	2021-07-08
Solid Forms Of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]- Piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-en- Enitrile App 20210198264 - Phiasivongsa; Pasit ; et al.	2021-07-01
Prodrugs of peptide epoxy ketone protease inhibitors Grant 10,682,419 - Phiasivongsa , et al.	2020-06-16
Processes for making triazolo[4,5D] pyramidine derivatives and intermediates thereof Grant 10,654,825 - By , et al.	2020-05-19
Processes For Making Triazolo[4,5d] Pyramidine Derivatives And Intermediates Thereof App 20180290999 - By; Kolbot ; et al.	2018-10-11
Prodrugs Of Peptide Epoxy Ketone Protease Inhibitors App 20180147291 - Phiasivongsa; Pasit ; et al.	2018-05-31
Prodrugs of peptide epoxy ketone protease inhibitors Grant 9,878,047 - Phiasivongsa , et al. January 30, 2	2018-01-30
Prodrugs Of Peptide Epoxy Ketone Protease Inhibitors App 20160263234 - Phiasivongsa; Pasit ; et al.	2016-09-15
Prodrugs of peptide epoxy ketone protease inhibitors Grant 9,315,542 - Phiasivongsa , et al. April 19, 2	2016-04-19
Prodrugs of peptide epoxy ketone protease inhibitors Grant 9,309,283 - Phiasivongsa , et al. April 12, 2	2016-04-12
Prodrugs of Peptide Epoxy Ketone Protease Inhibitors App 20140105921 - Phiasivongsa; Pasit ; et al.	2014-04-17
Prodrugs of Peptide Epoxy Ketone Protease Inhibitors App 20140100154 - Phiasivongsa; Pasit ; et al.	2014-04-10
Prodrugs of Peptide Epoxy Ketone Protease Inhibitors App 20140100168 - Phiasivongsa; Pasit ; et al.	2014-04-10
Synthetic methods and intermediates for steroisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders Grant 7,629,466 - By , et al. December 8, 2	2009-12-08
Synthetic Methods and Intermediates for Stereoisomeric Compounds Useful for the Treatment of Gastrointestinal and Central Nervous System Disorders App 20090137810 - By; Kolbot ; et al.	2009-05-28
Synthetic Methods and Intermediates for Stereoisomeric Compounds Useful for the Treatment of Gastrointestinal and Central Nervous System Disorders App 20080076927 - By; Kolbot ; et al.	2008-03-27
Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders Grant 7,326,787 - By , et al. February 5, 2	2008-02-05
Synthetic Methods and Intermediates for Stereoisomeric Compounds Useful for the Treatment of Gastrointestinal and Central Nervous System Disorders App 20070078265 - By; Kolbot ; et al.	2007-04-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.